The good genotype for clopidogrel metabolism is associated with decreased blood viscosity in clopidogrel-treated ischemic stroke patients
Background Blood viscosity (BV) is a measurement of the intrinsic resistance of blood to flow, and high BV increases thromboembolic risk. Although laboratory documentation of clopidogrel resistance has been shown to predict an increased risk of cardiovascular events in patients with ischemic stroke,...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Korean Neurocritical Care Society
2020-12-01
|
| Series: | Journal of Neurocritical Care |
| Subjects: | |
| Online Access: | http://e-jnc.org/upload/pdf/jnc-200023.pdf |